133 related articles for article (PubMed ID: 36736488)
1. The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis.
Zeng S; Xu Z; Liang Q; Thakur A; Liu Y; Zhou S; Yan Y
Chem Biol Interact; 2023 Mar; 373():110372. PubMed ID: 36736488
[TBL] [Abstract][Full Text] [Related]
2. CRABP2 reduces the sensitivity of Olaparib in ovarian cancer by downregulating Caspase-8 and decreasing the production of reactive oxygen species.
Zeng S; Xu Z; Liu Y; Zhou S; Yan Y
Chem Biol Interact; 2024 Apr; 393():110958. PubMed ID: 38493911
[TBL] [Abstract][Full Text] [Related]
3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
4. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
Yang Q; Zeng S; Liu W
PeerJ; 2023; 11():e15019. PubMed ID: 36949759
[TBL] [Abstract][Full Text] [Related]
5. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
[TBL] [Abstract][Full Text] [Related]
6. CRABP2 - A novel biomarker for high-risk endometrial cancer.
Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ
Gynecol Oncol; 2022 Nov; 167(2):314-322. PubMed ID: 36163055
[TBL] [Abstract][Full Text] [Related]
7. 4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5.
Ju J; Wang N; Wang J; Wu F; Ge J; Chen F
Drug Des Devel Ther; 2018; 12():997-1008. PubMed ID: 29731607
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of retinoic acid sensitivity in pancreatic cancer.
Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A
Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213
[TBL] [Abstract][Full Text] [Related]
9. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
[TBL] [Abstract][Full Text] [Related]
10. CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid.
Enikeev AD; Komelkov AV; Axelrod ME; Galetsky SA; Kuzmichev SA; Tchevkina EM
Biochemistry (Mosc); 2021 Feb; 86(2):217-229. PubMed ID: 33832420
[TBL] [Abstract][Full Text] [Related]
11. Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor.
Jiao X; Liu R; Huang J; Lu L; Li Z; Xu L; Li E
Curr Protein Pept Sci; 2020; 21(5):507-516. PubMed ID: 32013828
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma In Vivo and In Vitro.
Chen Q; Tan L; Jin Z; Liu Y; Zhang Z
Biomed Res Int; 2020; 2020():3098327. PubMed ID: 32685464
[TBL] [Abstract][Full Text] [Related]
13. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
14. Correlation between Plasma Cellular Retinoic Acid-Binding Protein 2 and Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells.
Meng JF; Luo MJ; Li HB
Crit Rev Eukaryot Gene Expr; 2021; 31(3):81-89. PubMed ID: 34369716
[TBL] [Abstract][Full Text] [Related]
15. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
[TBL] [Abstract][Full Text] [Related]
16. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer.
Mei J; Cai Y; Chen L; Wu Y; Liu J; Qian Z; Jiang Y; Zhang P; Xia T; Pan X; Zhang Y
Br J Cancer; 2023 Nov; 129(10):1645-1657. PubMed ID: 37715025
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.
Wu Y; Xie J; Wang H; Hou S; Feng J
J Clin Lab Anal; 2022 May; 36(5):e24408. PubMed ID: 35396749
[TBL] [Abstract][Full Text] [Related]
19. CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
Xie T; Tan M; Gao Y; Yang H
Environ Toxicol; 2022 Aug; 37(8):1957-1967. PubMed ID: 35442568
[TBL] [Abstract][Full Text] [Related]
20. Opposite Effects of CRABP1 and CRABP2 Homologs on Proliferation of Breast Cancer Cells and Their Sensitivity to Retinoic Acid.
Enikeev AD; Abramov PM; Elkin DS; Komelkov AV; Beliaeva AA; Silantieva DM; Tchevkina EM
Biochemistry (Mosc); 2023 Dec; 88(12):2107-2124. PubMed ID: 38462454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
